Gottlieb Advances, But FDA's Future Seems Increasingly Partisan

Senate committee votes to send the FDA Commissioner nominee to the Senate floor, but with only two Democratic votes.

Capitol House

Scott Gottlieb cleared the Senate Health, Education, Labor and Pensions Committee with bipartisan support, but Democratic rancor signals a potentially contentious relationship between the opposition party and FDA.

Democrats remain concerned about Gottlieb's ties to industry and the potential to create conflicts of interest. The 14-9 committee vote...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA

More from Agency Leadership